Systematic review of phase-I/II trials enrolling refractory and recurrent Ewing sarcoma: Actual knowledge and future directions to optimize the research.
Arthur FelixPablo BerlangaMaud ToulmondeJudith Landman-ParkerSarah DumontGilles VassalMarie-Cécile Le DeleyNathalie GasparPublished in: Cancer medicine (2021)
This review supports the need to develop the international randomized phase-II trials across all age ranges with PFS as primary endpoint.